Patient-reported disease burden in oculopharyngeal muscular dystrophy

被引:8
|
作者
Kurtz, Nicolette S. [1 ]
Cote, Claudia [2 ]
Heatwole, Chad [3 ]
Gagnon, Cynthia [2 ]
Youssof, Sarah [1 ]
机构
[1] Univ New Mexico, Dept Neurol, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Sherbrooke Univ, Ctr Rech Charles Moyne Saguenay Lac St Jean Innov, Sherbrooke, PQ, Canada
[3] Univ Rochester, Dept Neurol, New York, NY USA
关键词
coping strategies; dysphagia; impaired mobility; neuromuscular disease; qualitative study; QUALITY-OF-LIFE; RESILIENCE; SYMPTOMS; DYSPHAGIA; IMPACT; CARE;
D O I
10.1002/mus.26712
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction There is currently little evidence regarding oculopharyngeal muscular dystrophy (OPMD) disease burden reported by patients. In this study we aim to elicit direct patient input regarding OPMD disease burden. Methods We conducted semistructured interviews with 25 participants with genetically confirmed OPMD and a wide range of disease duration (15 +/- 8 years). Using the Framework Technique, themes and categories were then extracted. Results Analyses revealed 7 themes (physical impact, mental impact, social impact, perception of progression, treatment perceptions, coping strategies, and access to disease information), encompassing 27 categories of OPMD disease burden. The most frequent categories were related to dysphagia, coping strategies for dysphagia, and impaired mobility. Discussion This study demonstrates the importance of considering, when providing clinical care, the broad range of coping strategies patients use to deal with OPMD symptoms, especially dysphagia, to properly assess limitations and monitor real disease progression.
引用
收藏
页码:724 / 731
页数:8
相关论文
共 50 条
  • [41] A study of impairments in oculopharyngeal muscular dystrophy
    Brisson, Jean-Denis
    Gagnon, Cynthia
    Brais, Bernard
    Cote, Isabelle
    Mathieu, Jean
    MUSCLE & NERVE, 2020, 62 (02) : 201 - 207
  • [42] Molecular investigation of Oculopharyngeal Muscular Dystrophy
    Patrick, Dion
    Aida, Abu-Baker
    Christiane, Messaed
    Guy, Rouleau
    NEUROMUSCULAR DISORDERS, 2006, 16 : S103 - S103
  • [43] Chemosensory Loss in Oculopharyngeal Muscular Dystrophy
    Doppalapudi, Lalasa
    Hirsch, Alan
    NEUROLOGY, 2021, 96 (15)
  • [44] Correction of blepharoptosis in oculopharyngeal muscular dystrophy
    Kang, DH
    Koo, SH
    Ahn, DS
    Park, SH
    Yoon, ES
    ANNALS OF PLASTIC SURGERY, 2002, 49 (04) : 419 - 423
  • [45] Oculopharyngeal muscular dystrophy or oculopharyngeal distal myopathy: case report
    Maeda, Marilia Yuri
    Hashimoto, Tais Yuri
    Oliveira Neto, Isabella Christina
    Neves, Luciano Rodrigues
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2017, 83 (02) : 235 - 238
  • [46] Management of chronic pain in a patient with newly diagnosed oculopharyngeal muscular dystrophy
    Rhodes, K.
    Edipoglu, I.
    Marasinghe, C.
    Lecybyl, R.
    ANAESTHESIA, 2023, 78 : 55 - 55
  • [47] Gene therapy for oculopharyngeal muscular dystrophy
    Malerba, A.
    Klein, P.
    Bachtarzi, H.
    Jarmin, S.
    Cordova, G.
    Ferry, A.
    Strings, V.
    Espinoza, M. Polay
    Mamchaoui, K.
    Blumen, S.
    St Guily, J. Lacau
    Mouly, V.
    Graham, M.
    Butler-Browne, G.
    Suhy, D.
    Trollet, C.
    Dickson, G.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S245 - S246
  • [48] No evidence for heterogeneity in oculopharyngeal muscular dystrophy
    Kress, W
    Halliger-Keller, B
    Grimm, T
    Porschke, H
    Engelhardt, A
    Goebel, HH
    Müller-Mysok, B
    JOURNAL OF MEDICAL GENETICS, 1998, 35 (07) : 613 - 614
  • [49] Oculopharyngeal muscular dystrophy: postoperative complications
    Hélène G. Pellerin
    Pierre C. Nicole
    Claude A. Trépanier
    Martin R. Lessard
    Canadian Journal of Anesthesia, 2005, 52 (Suppl 1): : A192 - A192
  • [50] Swallowing Characteristics Pre And Post Exercise In A Patient With Oculopharyngeal Muscular Dystrophy
    Lausch, Anna
    Lamb, Katelyn
    Alumbaugh, Brent
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (09) : 430 - 430